Perlmutter Cancer Center Expands Clinical Trials Program
Perlmutter Cancer Center’s clinical trials program has grown due to an expanded phase I portfolio, biobanking, and other initiatives.
Perlmutter Cancer Center Expands Services on Long Island
With NYU Langone Health and NYU Winthrop Hospital’s merger, Perlmutter Cancer Center’s services expand on Long Island.
Perlmutter Cancer Center Expands to Long Island
NYU Langone’s Perlmutter Cancer Center expands clinical and research activities on Long Island, opening of a new facility in Huntington.
Perlmutter Cancer Center Hosts Immunotherapy Patient Summit
Experts from NYU Langone’s Perlmutter Cancer Center informed cancer patients, caregivers, and advocates of new breakthroughs in immunotherapy.
Perlmutter Cancer Center Institutional Profile
NYU Langone medical oncologist Dr. Catherine S. Diefenbach discusses clinical trials supported by the ECOG-ACRIN cooperative group.
Perlmutter Cancer Center Joins Call for HPV Vaccination
NYU Langone’s Perlmutter Cancer Center joins a national campaign to encourage vaccination against HPV, a cause of cervical and other cancers.
Perlmutter Cancer Center Joins Prestigious Lung Cancer Group
NYU Langone Health’s Perlmutter Cancer Center became 1 of 23 institutions to join a prestigious thoracic oncology research group.
Perlmutter Cancer Center Launches Biologics Program
A pioneering program in biologics at NYU Langone’s Perlmutter Cancer Center will be led by protein engineering expert Shohei Koide, PhD.
Perlmutter Cancer Center Launches New Disease Monitoring Protocol
The Center for Molecular Oncology at NYU Langone’s Perlmutter Cancer Center will launch a new protocol for patients diagnosed with early-stage and advanced cancers.
Perlmutter Cancer Center Launches New Lung Cancer Center
NYU Langone’s Perlmutter Cancer Center launches new multidisciplinary program to battle lung cancer.